AVENUE THERAPEUTICS INC (ATXI) Stock Balance Sheet
NASDAQ:ATXI - Nasdaq - US05360L4032 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 2.60M | 1.78M | 6.71M | 3.76M | 3.13M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | N/A | N/A | 0.00 | 90.00K | N/A | |||
| Other Current Assets | 28.00K | 67.00K | 137.00K | 107.00K | 113.00K | |||
| Total Current Assets | 2.63M | 1.85M | 6.84M | 3.96M | 3.25M | |||
| Non-Current Assets | ||||||||
| Total Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL ASSETS | 2.63M | 1.85M | 6.84M | 3.96M | 3.25M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 287.00K | 209.00K | 612.00K | 147.00K | 714.00K | |||
| Accounts Payable | 657.00K | 401.00K | 358.00K | 362.00K | 172.00K | |||
| Other Current Liabilities | 29.00K | 586.00K | 2.61M | N/A | 0.00 | |||
| Total Current Liabilities | 973.00K | 1.20M | 3.58M | 509.00K | 886.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Total Non-Current Liabilities | -958.00K | -928.00K | -639.00K | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 15.00K | 268.00K | 2.94M | 509.00K | 886.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -101.04M | -90.93M | -80.55M | -77.00M | -73.27M | |||
| Additional Paid In Capital | 103.65M | 92.51M | 84.46M | 80.45M | 75.63M | |||
| Minority Interest | -958.00K | -928.00K | -639.00K | N/A | N/A | |||
| Common Shares | 160.00 | 3.00K | 0.00 | 2.00K | 2.00K | |||
| Treasury Stock | N/A | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | -160.00 | N/A | 0.00 | N/A | N/A | |||
| Shares Outstanding | 1.60M | 341.00K | 64.00K | 19.00K | 15.00K | |||
| Tangible Book Value per Share | 1.63 | 4.64 | 61.02 | 181.63 | 157.27 | |||
| Total Shareholders' Equity | 2.61M | 1.58M | 3.90M | 3.45M | 2.36M | |||
| TOTAL LIABILITIES AND EQUITY | 2.63M | 1.85M | 6.84M | 3.96M | 3.25M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 2.70 | 1.55 | 1.91 | 7.78 | 3.66 | |||
| Return On Assets (ROA) | -360.69% | -560.92% | -51.89% | -94.22% | -158.74% | |||
| Return On Equity (ROE) | -362.76% | -655.94% | -90.96% | -108.11% | -218.36% | |||
All data in USD , ROIC based on taxRate of 0.21